Cmml | List of Frontiers open access articles

Case Report

Published on 30 Jul 2021

Massive Right Atrial Thrombosis: Are You Brave Enough to Start Anticoagulation? A Case Report

in General Cardiovascular Medicine

Marco Bergonti
Ciro Ascione
Piergiuseppe Agostoni
Roberto Castelli
Carlo Vignati

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.688351

4,012 views
3 citations

Original Research

Published on 12 Apr 2018

Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia

in Hematologic Malignancies

Tiphanie Picot
Carmen Mariana Aanei
Pascale Flandrin Gresta
Pauline Noyel
Sylvie Tondeur
Emmanuelle Tavernier Tardy
Denis Guyotat
Lydia Campos Catafal

Frontiers in Oncology

doi 10.3389/fonc.2018.00109

11,651 views
26 citations

Original Research

Published on 01 Jul 2024

Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis

in Hematologic Malignancies

Blanca Xicoy
Helena Pomares
Mireia Morgades
Ulrich Germing
Montserrat Arnan
Mar Tormo
Laura Palomo
Elisa Orna
Matteo Della Porta
Felicitas Schulz

Frontiers in Oncology

doi 10.3389/fonc.2024.1385987

4,034 views
4 citations

Brief Research Report

Published on 22 Aug 2025

Raw lacquer-associated familial chronic myelomonocytic leukemia with multi-hit TET2 mutations

in Molecular and Cellular Oncology

Yang Zhang
Yujiao Luo
Hongling Peng
Yafei Yin
Guangsen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1605369

1,360 views

Systematic Review

Published on 30 Sep 2021

Molecular Pathogenesis of Chronic Myelomonocytic Leukemia and Potential Molecular Targets for Treatment Approaches

in Hematologic Malignancies

Klaus Geissler

Frontiers in Oncology

doi 10.3389/fonc.2021.751668

7,475 views
8 citations

Original Research

Published on 15 Jan 2026

Clinical perception and novel insights of chronic myelomonocytic leukemia: a 10-year multi-center retrospective study

in Hematology

Yanquan Liu
Zhimin Yan
Jingdong Zhang
Xiaojun Chen
Jianzhen Shen
Honghua He
Yue Yin
Huidong Guo
Fanlin Zeng

Frontiers in Medicine

doi 10.3389/fmed.2025.1711684

761 views

Case Report

Published on 02 May 2024

Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report

in Hematologic Malignancies

Elisa Diral
Gloria Catalano
Maria Vittoria Cicinelli
Andrea Distefano
Sara Mastaglio
Luca Vago
Maria Teresa Lupo Stanghellini
Massimo Bernardi
Maurilio Ponzoni
Fabio Ciceri

Frontiers in Oncology

doi 10.3389/fonc.2024.1399894

1,755 views

Mini Review

Published on 13 Dec 2021

Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?

in Hematologic Malignancies

Konstantinos Liapis
Ioannis Kotsianidis

Frontiers in Oncology

doi 10.3389/fonc.2021.801524

12,669 views
11 citations

Brief Research Report

Published on 02 May 2024

A real-world experience of venetoclax combined with hypomethylating agents vs. monotherapy hypomethylating agents in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia patients

in Drugs Outcomes Research and Policies

Ludan Zhang
Rui Ge
Deng Pan
Pengjie Yue
Jingwen Zhang
Renjie Bian
Xiaojing Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1265840

3,512 views
2 citations

Case Report

Published on 07 Sep 2023

Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase

in Hematologic Malignancies

Emmanuella Oyogoa
Lukas Streich
Philipp W. Raess
Theodore Braun

Frontiers in Oncology

doi 10.3389/fonc.2023.1217153

2,821 views
3 citations

Case Report

Published on 04 Feb 2026

Case Report: Chronic myelomonocytic leukemia initially diagnosed as immune thrombocytopenia

in Blood Cancer

Jiaxin Wu
Hongxiang Wang

Frontiers in Hematology

doi 10.3389/frhem.2026.1748301

487 views

Review

Published on 03 Nov 2022

The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy

in Hematologic Malignancies

Taotao Li
Gaoling Zhang
Xiaoling Zhang
Hai Lin
Qiuju Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1015792

7,904 views
13 citations

Original Research

Published on 13 Jun 2024

No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine—a prospective multicenter study by the Polish Adult Leukemia Group

in Hematologic Malignancies

Krzysztof Mądry
Karol Lis
Elzbieta Sienkiewicz
Joanna Drozd-Sokołowska
Przemysław Biecek
Oktawia Sośnia
Aleksandra Gołos
Magdalena Olszewska-Szopa
Agata Obara
Zuzanna Walkowiak

Frontiers in Oncology

doi 10.3389/fonc.2024.1404322

3,594 views
2 citations

Review

Published on 05 Aug 2022

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders

in Hematologic Malignancies

Argiris Symeonidis
Spiros Chondropoulos
Evgenia Verigou
Vasileios Lazaris
Alexandra Kourakli
Panagiotis Tsirigotis

Frontiers in Oncology

doi 10.3389/fonc.2022.884723

6,954 views
8 citations

Case Report

Published on 19 Oct 2022

Inherited heterozygous Fanconi anemia gene mutations in a therapy-related CMML patient with a rare NUP98-HOXC11 fusion: A case report

in Hematologic Malignancies

Kefeng Shen
Meilan Zhang
Jiachen Wang
Wei Mu
Jin Wang
Chunyan Wang
Shugang Xing
Zhenya Hong
Min Xiao

Frontiers in Oncology

doi 10.3389/fonc.2022.1036511

4,932 views
3 citations

Articles

Massive Right Atrial Thrombosis: Are You Brave Enough to Start Anticoagulation? A Case Report

Evaluation by Flow Cytometry of Mature Monocyte Subpopulations for the Diagnosis and Follow-Up of Chronic Myelomonocytic Leukemia

Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis

Raw lacquer-associated familial chronic myelomonocytic leukemia with multi-hit TET2 mutations

Molecular Pathogenesis of Chronic Myelomonocytic Leukemia and Potential Molecular Targets for Treatment Approaches

Clinical perception and novel insights of chronic myelomonocytic leukemia: a 10-year multi-center retrospective study

Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report

Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?

A real-world experience of venetoclax combined with hypomethylating agents vs. monotherapy hypomethylating agents in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia patients

Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase

Case Report: Chronic myelomonocytic leukemia initially diagnosed as immune thrombocytopenia

The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy

No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine—a prospective multicenter study by the Polish Adult Leukemia Group

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders

Inherited heterozygous Fanconi anemia gene mutations in a therapy-related CMML patient with a rare NUP98-HOXC11 fusion: A case report